Singapore, April 16 -- During Abu Dhabi Global Health Week (ADGHW), the Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, and the Abu Dhabi Investment Office (ADIO) signed a Memorandum of Understanding (MoU) with GSK, global biopharmaceutical leader, to collaborate on a Multi-omics Research Institute in Abu Dhabi.

This transformative collaboration aims to accelerate oncology-focused genomic science and precision medicine, enhancing diversification and global representation in genomic research to improve cancer patient outcomes.

Multi-omics is a research approach that studies different biological molecules, such as genes, RNA, proteins, and metabolites, to understand how they interact in an or...